Paeds SAQs · haematology-oncology-and-transfusion
Bleeding child: diagnostic approach: SAQ
Short-answer questions covering a preschool child with immune thrombocytopenia and a separate boy with a possible haemophilia, exploring the platelet-versus-coagulation diagnostic approach and the bleeding history.
On this page
Study tools
Target exams
Part A (10 marks)
a) What is the most likely diagnosis, and which two features of the presentation confirm that this is a primary-hemostasis (platelet-type) rather than a coagulation-type problem? (3 marks) [1]
The most likely diagnosis is immune thrombocytopenia, suggested by the sudden onset of petechiae and bruising in an otherwise well child one to two weeks after a viral illness, with isolated severe thrombocytopenia and no blast cells on the film. The two features confirming a primary-hemostasis problem are the petechial, mucocutaneous bleeding pattern, which is immediate and superficial, and the isolated thrombocytopenia with a normal prothrombin and activated partial thromboplastin time, excluding a coagulation-factor deficiency. [1]
b) Which single investigation is essential before any corticosteroid therapy is considered, and why? (3 marks) [3]
A peripheral blood film reviewed for blast cells is essential, together with the haemoglobin and white cell count, to exclude acute lymphoblastic leukaemia. Treating suspected immune thrombocytopenia with steroids before excluding leukaemia can mask the diagnosis and delay definitive chemotherapy. The absence of additional cytopenias, blasts, hepatosplenomegaly, and lymphadenopathy supports immune thrombocytopenia, but the film must be confirmed before treatment. [3]
c) Outline the immediate management priorities for this child. (3 marks) [4]
A well child with immune thrombocytopenia and only skin bleeding can be observed with a clear safety-net and early review, because most acute immune thrombocytopenia resolves spontaneously. Treatment with corticosteroids or intravenous immunoglobulin at 0.8 to 1 g per kg is reserved for significant bleeding, a very low count with risk features, or an urgent need to raise the count. Avoid intramuscular injections and invasive procedures. The family must be safety-netted to present immediately with head injury, severe headache, or any significant bleeding, because intracranial haemorrhage is the catastrophic risk. [4]
d) Why is the bleeding assessment tool useful in the initial evaluation of a child with bruising, and when should it be applied? (1 mark) [1]
The bleeding assessment tool quantifies whether the bleeding is truly abnormal, separating pathological bleeding from normal childhood bruising far better than clinical impression, and it should be applied before expensive tier-two tests are ordered. [1]
References4ShowHide
- [1]van Ommen CH, Peters M The bleeding child. Part I: primary hemostatic disorders. Eur J Pediatr, 2012.PMID 21800040
- [2]van Herrewegen F, Meijers JC, Peters M, et al Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis. Eur J Pediatr, 2012.PMID 21922352
- [3]Neunert C, Terrell DR, Arnold DM, et al American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv, 2019.PMID 31794604
- [4]Neunert CE, Arnold DM, Grace RF, et al The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Adv, 2024.PMID 38608258